Format

Send to

Choose Destination
Trends Pharmacol Sci. 2006 Jun;27(6):317-23. Epub 2006 May 6.

PKD at the crossroads of DAG and PKC signaling.

Author information

1
Department of Pharmacology, University of Pittsburgh, Pittsburgh, PA 15261, USA. qjw1@pitt.edu

Abstract

Diacylglycerol (DAG) and its primary target protein kinase C (PKC) regulate many important cellular responses, yet the molecular mechanisms that control the specificity of DAG and PKC signaling are not fully understood. As such, targeting the PKC pathway for therapeutic purposes has been challenging. Protein kinase D (PKD), a novel DAG receptor, has been the subject of intense investigation in recent years. DAG regulates the intracellular localization of PKD and also activates PKD through PKC by phosphorylation. The PKC-PKD signaling cascade is crucial to PKD function in cells. Important discoveries have been made regarding the roles of PKD in cell growth, gene expression, survival, motility, protein trafficking and lymphocyte biology. This kinase is implicated in pathological processes such as cardiac hypertrophy, tumor cell proliferation and metastasis. Thus, PKD represents a novel therapeutic target for the DAG-PKC signaling network.

PMID:
16678913
DOI:
10.1016/j.tips.2006.04.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center